Cargando…

Multiple drugs: Prolongation of the clinical course in severe acute respiratory syndrome coronavirus 2 infection and off label use : case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486158/ http://dx.doi.org/10.1007/s40278-020-83304-6

Ejemplares similares

Multiple drugs: Severe acute respiratory syndrome coronavirus 2 reinfection and off label use: case report
Publicado: (2021)

Multiple drugs: Severe acute respiratory syndrome coronavirus 2 infection, renal dysfunction and off label use: case report
Publicado: (2020)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Ocrelizumab: Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Publicado: (2022)

Corticosteroid Responsive Encephalopathy: Prolonged Coma in Patients Late in the Course of Dreadful Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Montaut, Victor, et al.
Publicado: (2020)

Multiple drugs: Off-label use and prolonged viral clearance: case report
Publicado: (2021)

Multiple drugs: Prolonged viral shedding time and off-label use: case report
Publicado: (2020)

Multiple drugs: Severe COVID-19, prolonged viral shedding, lack of efficacy and off-label use: case report
Publicado: (2022)

Multiple drugs: COVID-19 infection, prolonged viral shedding and off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: QTc prolongation, lack of efficacy and off-label use: 3 case reports
Publicado: (2021)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021)

Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19
por: Li, Qian, et al.
Publicado: (2020)

Multiple drugs: Infections and off label use: case report
Publicado: (2021)

Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus‐2 infection
por: Zhang, Shun, et al.
Publicado: (2021)

Multiple drugs: Acute pancreatitis, hypertriglyceridaemia and off-label use in coronavirus disease 2019: 2 case reports
Publicado: (2020)

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report
Publicado: (2021)

Multiple drug interactions: QTc time prolongation following off-label use: 3 case reports
Publicado: (2022)

Multiple drugs: DRESS syndrome and off label use: case report
Publicado: (2021)

Multiple drugs: Acute pancreatitis and off label use: case report
Publicado: (2021)

Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)

Protracted course of coronavirus disease with severe acute respiratory distress syndrome: a case report
por: Miyamoto, Kyohei, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome–associated Coronavirus Infection
por: Chan, Paul K.S., et al.
Publicado: (2003)

Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
por: Ueno, Akitoshi, et al.
Publicado: (2021)

Multiple drugs: Atrial fibrillation, Bradycardia, QTC interval prolongation and off label use: 2 case reports
Publicado: (2021)

Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
por: Price, Susanna, et al.
Publicado: (2020)

Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
por: Ozieranski, Krzysztof, et al.
Publicado: (2021)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Multiple drugs: Severe acute respiratory syndrome coronavirus-2 infection, influenza-A virus infection and lack of efficacy: 3 case reports
Publicado: (2020)

Severe Acute Respiratory Syndrome and Coronavirus
por: Hui, David S.C., et al.
Publicado: (2010)

Clustering and multiple-spreading events of nosocomial severe acute respiratory syndrome coronavirus 2 infection
por: Jung, J., et al.
Publicado: (2021)

Multiple drugs: Severe diarrhoea, off label use and treatment failure: case report
Publicado: (2022)

Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection
por: Lee, Harold K.K., et al.
Publicado: (2003)

In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Von Kohorn, Isabelle, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
por: Chow, Eric J., et al.
Publicado: (2022)

Autophagy in severe acute respiratory syndrome coronavirus 2 infection
por: Chen, Di, et al.
Publicado: (2022)

Multiple drugs: Coronavirus disease-2019, lack of efficacy and off-label treatment: 21 case reports
Publicado: (2021)

Coronavirus Disease 2019 Causing Infection of Transplanted Lung Allograft: A Pitfall of Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus-2 Pretransplant
por: Shah, Sadia Z., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ul0ll7rc66s4dsg593vfbu2qj0